K-MoCA-22

There is 1 paper on K-MoCA-22 in aging research: 1 observational study in people.

Biomarker

1 paper studies it3 more mention it2 findings

See all 4 papers on K-MoCA-22

“the area under the curve (AUC) for K-MoCA-22 was significantly smaller than that for K-MoCA-30 in distinguishing both MCI and dementia from CN.”
Differential Validity of K-MoCA-22 Compared to K-MoCA-30 and K-MMSE for Screening MCI and DementiaDementia and neurocognitive disorders2024doi:10.12779/dnd.2024.23.4.236
  • Humans1

Effects

1

Discrimination of mild cognitive impairment and dementia

no changein humans1downin humans1

1 study
  1. K-MoCA-22 was not clearly linked with discrimination of mild cognitive impairment and dementia in humans (Compared with K-MMSE).

    “no significant difference in AUC was found between K-MoCA-22 and K-MMSE, indicating similar discriminatory power.”

    HumansCompared with K-MMSE

    Differential Validity of K-MoCA-22 Compared to K-MoCA-30 and K-MMSE for Screening MCI and Dementia

    Dementia and neurocognitive disorders

  2. K-MoCA-22 is linked with lower discrimination of mild cognitive impairment and dementia in humans.

    “the area under the curve (AUC) for K-MoCA-22 was significantly smaller than that for K-MoCA-30 in distinguishing both MCI and dementia from CN.”

    HumansCompared with K-MoCA-30 for distinguishing MCI and dementia from cognitively normal individuals

    Differential Validity of K-MoCA-22 Compared to K-MoCA-30 and K-MMSE for Screening MCI and Dementia

    Dementia and neurocognitive disorders

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 02 papers in 12 months